Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Linderoth

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Haematology|April 19, 2008
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphomaJohan Linderoth, Patrik Edén, Mats Ehinger, et al.
Leukemia & Lymphoma|October 11, 2007
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTENMarie Fridberg, Anna Servin, Lola Anagnostaki, et al.
Ejhaem|July 18, 2022
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 yearsBjörn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, et al.
British Journal of Haematology|February 6, 2016
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational studyLasse H Jakobsen, Martin Hutchings, Peter de Nully Brown, et al.
Blood Advances|April 1, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphomaNinja Övergaard, Kjersti Lia, Jeremia Collin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosisMattias Berglund, Ulf Thunberg, Rose-Marie Amini, et al.
British Journal of Haematology|October 16, 2019
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapyIngemar Lagerlöf, Harald Holte, Ingrid Glimelius, et al.
Clinical and Translational Medicine|December 6, 2022
The dual role of CD70 in B-cell lymphomagenesisMan Nie, Weicheng Ren, Xiaofei Ye, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Haematology|April 19, 2008
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphomaJohan Linderoth, Patrik Edén, Mats Ehinger, et al.
Leukemia & Lymphoma|October 11, 2007
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTENMarie Fridberg, Anna Servin, Lola Anagnostaki, et al.
Ejhaem|July 18, 2022
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 yearsBjörn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, et al.
British Journal of Haematology|February 6, 2016
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational studyLasse H Jakobsen, Martin Hutchings, Peter de Nully Brown, et al.
Blood Advances|April 1, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphomaNinja Övergaard, Kjersti Lia, Jeremia Collin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosisMattias Berglund, Ulf Thunberg, Rose-Marie Amini, et al.
British Journal of Haematology|October 16, 2019
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapyIngemar Lagerlöf, Harald Holte, Ingrid Glimelius, et al.
Clinical and Translational Medicine|December 6, 2022
The dual role of CD70 in B-cell lymphomagenesisMan Nie, Weicheng Ren, Xiaofei Ye, et al.
Pageof 2